We are sharing a specialised part-time consulting opportunity for experienced biotech investment professionals with deep expertise in evaluating pharmaceutical assets, clinical-stage drug-development programmes, company fundamentals, and investment opportunities within the US biotech and healthcare market. This role supports an expert evaluation initiative focused on commercial drugs and drug-development programmes. Selected professionals will develop and critique structured evaluation rubrics, assess individual drug assets and the companies behind them, and apply specialist investment judgement across a focused set of biotech companies. Key Responsibilities Drug Asset Assessment Evaluate commercial and clinical-stage drug assets across different therapeutic areas Assess mechanism of action, biological rationale, clinical data, development progress, and regulatory considerations Analyse competitive positioning within relevant therapeutic and treatment landscapes Identify key scientific, clinical, regulatory, and commercial value drivers Flag unsupported assumptions, evidence gaps, or material risks within asset assessments Company & Investment Analysis Conduct end-to-end assessments of biotech and pharmaceutical companies Evaluate pipeline quality, company strategy, competitive differentiation, and major catalysts Assess the relationship between individual drug assets and overall company valuation Review investment-style theses for analytical strength, supporting evidence, and internal consistency Identify weak, overly confident, or missing assumptions within investment conclusions Apply consistent investment judgement across approximately 5–10 companies during the pilot Clinical & Commercial Evaluation Interpret clinical trial results and assess the strength and relevance of available evidence Evaluate potential differentiation against existing and emerging standards of care Analyse addressable markets, competitive dynamics, development timelines, and commercial opportunity Assess how clinical, regulatory, and market developments may affect asset and company value Distinguish between well-supported conclusions and speculative investment assumptions Rubric Development & Expert Review Create structured evaluation rubrics for biotech companies and drug-development programmes Critique existing rubrics for completeness, realism, and investment relevance Define criteria reflecting experienced biotech investment judgement Identify missing considerations or weak assumptions in analytical frameworks Provide clear written reasoning supporting evaluation decisions Ideal Profile 5+ years of experience evaluating biotech, pharmaceutical, or healthcare companies or assets Professional experience as a biotech or healthcare investment analyst, ideally within a specialist investment fund Strong familiarity with biotech and pharmaceutical drug-development programmes Experience assessing drug assets from scientific, clinical, commercial, and investment perspectives Strong understanding of clinical data, mechanisms of action, competitive landscapes, and biotech valuation drivers Ability to evaluate both individual assets and the broader companies developing them Experience developing, reviewing, or presenting investment theses Strong analytical judgement and ability to identify unsupported or incomplete assumptions US-based or possessing deep professional experience covering the US biotech and healthcare investment market Availability for approximately 10–20 hours over an initial 1–2 week pilot Engagement Details Part-time independent contractor engagement Approximately 10–20 hours over an initial 1–2 week pilot Fully remote with flexible scheduling Compensation of $125–$185/hour Potential for recurring project work for strong contributors Work must be completed without using confidential or proprietary information belonging to any employer, client, fund, institution, or other third party H1-B and STEM OPT support is unavailable for this engagement About the Platform This opportunity is available through 24-MAG LLC. We connect experienced professionals with remote consulting opportunities across technical, evaluation, and project-based workstreams. By submitting this application, you acknowledge that your information may be processed by 24-MAG LLC for recruitment and opportunity matching in accordance with our Privacy Policy: https://www.24-mag.com/privacy-policy .
Remote | Business Intelligence Analyst — $75–$110/hour
24 Mag
Remote | Finance Research Analyst — $65–$95/hour
24 Mag
Senior HR Technology Analyst - Hourly Compensation
Generalmotors
Enrollment Data & Storytelling Analyst (Graduate Student Hourly)
University of Wisconsin-Madison Login
Control Systems Analyst II (Off-hours)
GrayMatter Systems
AI Quality Analyst - Flexible Hours
Innodata Inc.